HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Krithika Subramanian, PhD


Targeting the NF-kB Pathway in Duchenne Muscular Dystrophy

December 24, 2019

An in-depth analysis of the genetics of DMD and disease modifiers such as the NF-kB pathway in patients with Duchenne muscular dystrophy.

Exploring the Role of B Cells and CD20 in Multiple Sclerosis

November 28, 2019

Although there are no cures for MS at present, the treatment landscape has changed significantly, with over a dozen approved disease-modifying therapies (DMTs) representing multiple classes of agents with different mechanisms of action.

CGRP: Paving the Path to Migraine and Its Treatment

September 30, 2019

After a long period of time with minimally effective treatments for migraine, the growing understanding of the CGRP pathway has opened the door to a variety of new and highly efficacious therapies for patients with chronic and episodic forms of disease.

Exploring the VMAT2 Pathway in Tardive Dyskinesia

June 30, 2019

VMAT2, given its role in presynaptic packaging, storage, and release of dopamine, has emerged as a promising target for therapeutic interventions to manage movement disorders.